TB vax: Serum Institute seeks emergency-use authorization Subject: Science and tech Section: COVID -19 Context: The Serum Institute has applied to the Drugs Controller General of India, seeking emergency use authorisation for its recombinant BCG (rBCG) vaccine for the prevention of tuberculosis, said official sources on Sunday. India’s TB immunisation programme currently offers […]
Central Drugs Standard Control Organisation (CDSCO) Subject – Governance Context – Expert panel clears Covaxin for emergency use in 218 age group Concept – Covaxin is the country’s first indigenous, whole-virion, inactivated vaccine developed by Bharat Biotech in collaboration with the Indian Medical Research Council (ICMR) and the National Institute of Virology (NIV). To know about CDSCO, please click here. CDSCO along […]